EP0743866A4 - Gefässokklusionsspirale mit grossem durchmesser - Google Patents

Gefässokklusionsspirale mit grossem durchmesser

Info

Publication number
EP0743866A4
EP0743866A4 EP19930904799 EP93904799A EP0743866A4 EP 0743866 A4 EP0743866 A4 EP 0743866A4 EP 19930904799 EP19930904799 EP 19930904799 EP 93904799 A EP93904799 A EP 93904799A EP 0743866 A4 EP0743866 A4 EP 0743866A4
Authority
EP
European Patent Office
Prior art keywords
coil
helical coil
helical
vessel
shaped structure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19930904799
Other languages
English (en)
French (fr)
Other versions
EP0743866A1 (de
Inventor
Uriel Hiram Chee
Mike Mariant
Erik T Engelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Ltd Barbados
Original Assignee
Target Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Target Therapeutics Inc filed Critical Target Therapeutics Inc
Publication of EP0743866A4 publication Critical patent/EP0743866A4/de
Publication of EP0743866A1 publication Critical patent/EP0743866A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • A61B17/12145Coils or wires having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers

Definitions

  • This invention is in the general field of surgical instruments. More particularly, it relates to a vasoocclusion device that can be used in cardiovascular and endovascular procedures.
  • Vasoocclusion devices are surgical implements that are placed within vessels, typically via a catheter, to block the flow of blood through the vessel.
  • Vasoocclusive coils have been used to occlude vessels in small-diameter, difficult to reach sites.
  • United States Patent No. 4,994,069 provides a vasoocclusive wire that is guided to a vessel that has a diameter of between 0.5 and 6 mm.
  • the patent describes a flexible vasoocclusive wire that is designed to occlude a vessel when the wire is released into the vessel.
  • the diameter of the coiled wire is between about 10-30 mils, the wire itself has an outside diameter of between about 2-6 mils and there are about 4-8 helical windings.
  • the wire has a preferred length o-f about : 3-6 cm, and for a vessel that is 2-6 mm, the wire has a preferred length of about 5-10 cm.
  • the device is a vasoocclusive coil that assumes a linear helical configuration when stretched and a folded convoluted configuration when relaxed. The stretched condition is used in placing the coil at the desired site and the coil assumes its relaxed configuration once the device is so placed.
  • the vasoocclusive device is a helical coil having a multiplicity of windings between a first and second end wherein the primary coil diameter is between about 0.25 and 1.5 mm and the diameter of the vessel to be occluded is between about 1.0 and 3.0 cm. Once relaxed, the coil may assume a secondary coil diameter approaching that of the selected vessel.
  • Figs. 1 to 9 are fragmentary elevational views (not to scale) of embodiments of the helical coil of the invention.
  • FIG* 1 depicts one embodiment, generally designated 10, of the helical vasoocclusive coil of the invention.
  • the helical coil 10 will typically be made of a radiopaque material such as platinum, tungsten, gold, stainless steel, or of alloys such as tungsten and platinum.
  • a tungsten-platinum alloy is preferred because of its strength and toughness.
  • the material desirably is radiopaque and the diameter of the wire will usually be in the range of 0.05 to 0.25 mm.
  • the coil has a multiplicity of individual windings 12.
  • the axial length of the coil will usually be in the range of 0.2 to 100 cm, more usually 0.2 to 40 cm and the diameter of the coil will normally be 0.25 and 1.5 mm, more usually 0.5 to 1.0 mm.
  • the coil will typically have about 40 to 200 windings per cm, more typically about 50 to 130 windings per cm.
  • the steps in the construction of the vasoocclusion coils of this invention are shown in Figs. 1-3.
  • the coil itself may be formed by wrappings of windings of a fine radiopaque wire thread, preferably 5 ⁇ to 8 mil (0.13 to 0.20 mm) platinum, tungsten, gold, stainless steel or alloy thread which is available, for example, from California Fine Wire Company (Grover City, CA) .
  • the windings are preferably made by wrapping the thread on a spinning mandrel, according to known coil- manufacturing methods.
  • the wire advance on the mandrel is adjusted to produce a single-layer coil with a minimum helical pitch, i.e., in which the windings are closely packed.
  • the mandrel has a diameter of between about 0.10 and 1.0 mm yielding a coil whose outer diameter is between about 0.25 and 1.5 mm.
  • the soft, flexible coil produced on the mandrel is cut to a desired length of between about 4 and 100 cm after removal from the mandrel.
  • the coiled wire may then be wound on a larger diameter mandrel to form a helical winding as shown in Fig. 2 whose helix diameter, indicated at 14, is approximately that of the vessel for which the coil is intended.
  • the helical axis is indicated at 16.
  • the diameter of this secondary helical winding is preferably 1-3 cm, respectively. It can be appreciated from the above-mentioned wire lengths and winding diameters, that the wires typically will contain 1-20 helical windings, more typically 4-8 helical windings as illustrated in Fig. 2.
  • the coil may further be preformed to contain irregularities in the helical winding, such that the coil adopts a folded, convoluted conformation in a relaxed condition as illustrated in Fig. 3.
  • the irregularities in this embodiment are such as to offset the helical axis (indicated by arrows in the figure) of each winding by 20-40 degrees.
  • the irregularities are preferably made by deforming, as. by twisting, the coil in the region of desired bends with the coil on the helical winding mandrel.
  • the coil may treated by heating at about 800°F for about 24 hours for memory retention after it is shaped.
  • the combination of the helical winding and the irregularities in the winding cause the coil to form a randomly shaped, substantially space-filling mass when released into a vessel, as will be illustrated below.
  • the memory in the coil is effective to return the coil from a stretched, linear condition in which it is advanced through a catheter to a randomly oriented, space-filling relaxed condition as the coil is released from the catheter.
  • the coil just described may be thought of as having a primary structure formed by the wire wrapping making up.the coil, a secondary structure formed by the helical winding of the coil, and a tertiary structure formed by the irregularities in the winding of the coil. It will be appreciated that the random shape of the coil in its relaxed condition can be achieved by other, related secondary structures in the coil, such as a series of arcs which are interrupted at intervals by bends which orient the arcs in different directions.
  • the primary helical coil may be wound around a series of mandrels that are held in some uniform configuration to yield the offset helical shape shown in Fig. 3. Multiple coils may be formed in this way and thereafter the coils may be cut to form individual vasoocclusive coils.
  • the coil is preferably supplied in prepackaged form in a sterile cannula.
  • the cannula straightens the coil during shipment such that it can be placed within a catheter lumen for delivery to the targeted vessel.
  • a guidewire is inserted such that a catheter can be guided to the targeted vessel.
  • the guidewire is removed and the coil-containing cannula is placed into engagement with the proximal end of the catheter.
  • the coil is then transferred from the cannula lumen into the catheter lumen by exerting force on the proximal end of the coil.
  • the coil is advanced through the catheter to the tissue of interest by means a guidewire or coil pusher that pushes against the proximal end of the coil.
  • water may be injected into the catheter to force the coil through the catheter lumen.
  • the location of the coil may be visualized due to the radiopacity of the helical coil. Once at the site, the coil is plunged from the distal end of the catheter into the targeted vessel.
  • the coil is supplied in a cannula which is adapted to engage the proximal end of a guidewire.
  • the coil-containing cannula is placed into engagement with the proximal end of the guidewire and the coil is transferred from the cannula lumen onto the guidewire by exerting force on the proximal end of the coil.
  • the coil is delivered to the targeted site by being pushed with a guidewire, coil pusher or by means of hydraulic injection as described above.
  • Figs, l to 9 show variants of the invention, but for simplicity of explanation, show the shape when the coil is in the catheter lumen (Figs. 1 and 7) and after release of the coil at the targeted site (Figs. 2 to 6, 8 and 9) .
  • Fig. 2 shows a partial side view of the helical coil 10 in its relaxed configuration.
  • the coil 10 will be placed inside the catheter lumen in its linear stretched form (as shown in Fig. 1) until discharged from the end of the catheter at which time the configuration shown in Fig. 2 will be assumed.
  • Fig, 3 shows another embodiment of a vasoocclusive coil of the invention after it has been released from the end of the catheter.
  • the coil loops back upon itself to form a secondary coil having a tertiary configuration that may substantially fill the vessel to be occluded.
  • Irregularities in the coil windings allow formation of the folded convoluted conformation in the coil's relaxed condition.
  • the multiple convolutions or irregularities in the embodiment are such as to offset the helical axis (the arrows in Fig. 3) of each winding by 20-40 degrees.
  • Figs. 4, 5, and 6 each illustrate a different aspect of the invention.
  • Fig. 3 shows a helical coil that forms a tertiary shape that is circular
  • Figs. 4-6 show additional coils whose tertiary structures are also useful in the invention.
  • Fig. 4 shows a cloverleaf- shaped vasoocclusive coil
  • Fig. 5 shows a figure-8-shaped
  • Fig. 6 shows a C-shaped vasoocclusive coil.
  • the tertiary structures are the relaxed configurations of the coils after release into the vessel.
  • the devices are introduced as helical coils as shown in Fig. l and then assume the shapes shown.
  • the maximum helical coil diameters of the coils shown as 20, 22 and 24 are equivalent to the size of the vessel to be occluded, that is 1-3 cm.
  • Figures 7 and 8 show a vasoocclusive coil such as is described above, but in which irregularities in the helical winding are produced by flattening the wire coil in different directions. This may be accomplished by flattening or squeezing the linear coil 30 in a number of places 32 along the winding at various angles (if so desired) such as is shown in Fig. 7.
  • the coil so formed will have the general appearance shown in Fig. 7 when in its linear configuration.
  • the coil will be in its linear configuration as shown in Fig. 7 during its introduction into the vessel, but will assume the shape shown in Fig. 8 when in its relaxed configuration.
  • Fig. 9 shows a coil having a primary coil structure as described above, with a helical winding 40 having at least one helical turn whose diameter 42 is the ( size of the vessel to be occluded.
  • the irregularities in the helical winding take the form of continually changing helical diameters forming spirals which are dimensioned to span the cross-sectional area of the vessel.
  • the coils of the present invention therefore are useful for occluding vessels in the range of about l to 3 cm.
  • Such applications include the occlusion of fistulas of the pulmonary vasculature in the lungs, trauma in -the periphery, arteriovenous malformations, heart anomalies and aneurysms.

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Surgical Instruments (AREA)
  • Disintegrating Or Milling (AREA)
  • Filling Or Discharging Of Gas Storage Vessels (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Burglar Alarm Systems (AREA)
EP93904799A 1992-11-19 1993-02-03 Gefässokklusionsspirale mit grossem durchmesser Withdrawn EP0743866A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97823092A 1992-11-19 1992-11-19
US978230 1992-11-19
PCT/US1993/000882 WO1994011051A1 (en) 1992-11-19 1993-02-03 Large diameter vasoocclusion coil

Publications (2)

Publication Number Publication Date
EP0743866A4 true EP0743866A4 (de) 1996-07-26
EP0743866A1 EP0743866A1 (de) 1996-11-27

Family

ID=25525882

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93904799A Withdrawn EP0743866A1 (de) 1992-11-19 1993-02-03 Gefässokklusionsspirale mit grossem durchmesser

Country Status (6)

Country Link
EP (1) EP0743866A1 (de)
JP (1) JPH08500273A (de)
AU (1) AU681073B2 (de)
CA (1) CA2144725C (de)
IL (1) IL104870A0 (de)
WO (1) WO1994011051A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5690671A (en) * 1994-12-13 1997-11-25 Micro Interventional Systems, Inc. Embolic elements and methods and apparatus for their delivery
US6176240B1 (en) 1995-06-07 2001-01-23 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6705323B1 (en) 1995-06-07 2004-03-16 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US5709224A (en) * 1995-06-07 1998-01-20 Radiotherapeutics Corporation Method and device for permanent vessel occlusion
US6270495B1 (en) 1996-02-22 2001-08-07 Radiotherapeutics Corporation Method and device for enhancing vessel occlusion
DK177010B1 (da) 1996-09-03 2010-11-29 Cook William Europ Embolisationsindretning til placering i et blodkar
US6551340B1 (en) 1998-10-09 2003-04-22 Board Of Regents The University Of Texas System Vasoocclusion coil device having a core therein
EP1040843B1 (de) 1999-03-29 2005-09-28 William Cook Europe A/S Ein Führungsdraht
CN1286443C (zh) 1999-08-23 2006-11-29 孕体股份有限公司 用于输卵管内避孕的插入/展开导管系统
US6709667B1 (en) 1999-08-23 2004-03-23 Conceptus, Inc. Deployment actuation system for intrafallopian contraception
EP1409058A2 (de) 2000-01-28 2004-04-21 William Cook Europe ApS Medizinische endovaskuläre vorrichtung mit einer mehrzahl von drähten
US6605101B1 (en) 2000-09-26 2003-08-12 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US7029486B2 (en) 2000-09-26 2006-04-18 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US7033374B2 (en) 2000-09-26 2006-04-25 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
CN105286937A (zh) * 2001-11-07 2016-02-03 微温森公司 血管阻塞器件
EP1448105B1 (de) * 2001-11-07 2009-12-23 Microvention, Inc. Gefässverschliessende mikrospiraleinrichtung mit multi-axialer sekundäranordnung
JP2005198895A (ja) * 2004-01-16 2005-07-28 Medicos Hirata:Kk 生体吸収性血管内閉塞コイル
WO2006032289A1 (de) 2004-09-22 2006-03-30 Dendron Gmbh Medizinisches implantat
US8845676B2 (en) 2004-09-22 2014-09-30 Micro Therapeutics Micro-spiral implantation device
US8864790B2 (en) 2006-04-17 2014-10-21 Covidien Lp System and method for mechanically positioning intravascular implants
CN101677821B (zh) 2007-03-13 2014-05-14 泰科保健集团有限合伙公司 植入物和轴柄
JP5249249B2 (ja) 2007-03-13 2013-07-31 コヴィディエン リミテッド パートナーシップ コイルと耐伸張性部材とが含まれているインプラント
US9579104B2 (en) 2011-11-30 2017-02-28 Covidien Lp Positioning and detaching implants
US9011480B2 (en) 2012-01-20 2015-04-21 Covidien Lp Aneurysm treatment coils
US9687245B2 (en) 2012-03-23 2017-06-27 Covidien Lp Occlusive devices and methods of use
JP6566961B2 (ja) 2014-02-27 2019-08-28 インキュメデックス インコーポレイテッド 塞栓骨組マイクロコイル
US9713475B2 (en) 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices
CA2955953A1 (en) 2014-07-25 2016-01-28 Incumedx, Inc. Covered embolic coils
US10307168B2 (en) 2015-08-07 2019-06-04 Terumo Corporation Complex coil and manufacturing techniques

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3203410A1 (de) * 1981-05-08 1982-11-25 VEB Kombinat Wälzlager und Normteile, DDR 9022 Karl-Marx-Stadt Verschlusskoerper und verfahren zu seiner herstellung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994069A (en) * 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
AU629658B2 (en) * 1990-04-26 1992-10-08 Semyon Gurevich A catheter device for the insertion of a dilator prosthesis into tubular organs of humans or animals

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3203410A1 (de) * 1981-05-08 1982-11-25 VEB Kombinat Wälzlager und Normteile, DDR 9022 Karl-Marx-Stadt Verschlusskoerper und verfahren zu seiner herstellung

Also Published As

Publication number Publication date
EP0743866A1 (de) 1996-11-27
IL104870A0 (en) 1993-06-10
JPH08500273A (ja) 1996-01-16
CA2144725A1 (en) 1994-05-26
WO1994011051A1 (en) 1994-05-26
AU681073B2 (en) 1997-08-21
CA2144725C (en) 2000-06-06
AU3603793A (en) 1994-06-08

Similar Documents

Publication Publication Date Title
CA2144725C (en) Large diameter vasoocclusion coil
EP0747013B1 (de) Dreidimensionale vaso-okklusive Füllwendeln
US5549624A (en) Fibered vasooclusion coils
EP1009294B1 (de) Anatomisch geformte vorrichtung zur gefässokklusion
US6860893B2 (en) Stable coil designs
US8226660B2 (en) Vaso-occlusive coils with non-overlapping sections
US6001092A (en) Complex coils having fibered centers
JP4783927B2 (ja) 選択的に平坦化された領域を有する脈管閉塞コイル
JP2004511293A (ja) 非オーバーラッピング球形三次元血管閉塞コイル
EP1307149A2 (de) Verfahren zur herstellung von gefässverschliessenden spiraleinrichtungen

Legal Events

Date Code Title Description
A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950313

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19990115

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: TARGET THERAPEUTICS, INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BOSTON SCIENTIFIC LIMITED

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020508